Inventor · disambiguated record
Ankit Vartak
Also filed as: VARTAK ANKIT
15 granted patents·8 pending applications·73 citations·filing 2020–2024
94Inventor score
Files withREGENERON PHARMA23
Top patents by PatentIndex Score
23 records- 0198US11459373B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Oct 4, 2022·8 cites·16 claims
- 0298US11459374B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Oct 4, 2022·13 cites·26 claims
- 0398US11299532B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Apr 12, 2022·8 cites·22 claims
- 0498US11174283B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Nov 16, 2021·13 cites·12 claims
- 0598US11053280B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Jul 6, 2021·19 cites·11 claims
- 0697US12049489B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Jul 30, 2024·2 cites·30 claims
- 0797US11649273B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted May 16, 2023·2 cites·28 claims
- 0897US11407813B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Aug 9, 2022·3 cites·20 claims
- 0994US12202883B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Granted Jan 21, 2025·0 cites·12 claims
- 1094US11505594B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Nov 22, 2022·1 cites·27 claims
- 1194US11180540B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Nov 23, 2021·2 cites·28 claims
- 1294US2025197474A1Anti-vegf protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1391US11286290B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Mar 29, 2022·1 cites·30 claims
- 1490US12077570B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Sep 3, 2024·0 cites·30 claims
- 1588US11098112B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Aug 24, 2021·1 cites·26 claims
- 1687US12054533B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Aug 6, 2024·0 cites·18 claims
- 1782US2023348532A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1882US2023331776A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1982US2023332084A1Bioreactor for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2082US2023287043A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2182US2023332201A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2282US2024010737A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2354US2023063116A1Vegf mini-traps and method of use thereofREGENERON PHARMA·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →